New clinical trial might change the standard treatment for melanoma – Washington Post
Washington Post |
New clinical trial might change the standard treatment for melanoma
Washington Post In a head-to-head comparison of two immunotherapy drugs used to prevent relapse in certain patients with advanced melanoma, one treatment was the clear winner — and it’s not the one that most people get. The international study, released Sunday, … After melanoma surgery, Bristol’s Opdivo offers new care standard Bristol-Myers posts data on an upset checkpoint combo victory in frontline kidney cancer |
View original article
Author:
Powered by WPeMatico
Health Topic Contributor
Editors and curators bringing you the latest and most impactful health news. Truly objective, we print links to stories and studies that may contradict one another. If you're searching for news on health studies, alternative health modalities, facts on modern allopathic medicine, and more, we're you're team bringing you the stories and facts that matter.